Cerezyme
Generic name: Imiglucerase
Drug class:
Lysosomal enzymes
Usage of Cerezyme
Cerezyme is a man-made form of an enzyme that occurs naturally in the body. It is used as an enzyme replacement in people with Type I Gaucher disease.
Gaucher disease is a genetic condition in which the body lacks the enzyme needed to break down certain fatty materials (lipids). Lipids can build up in the body, causing symptoms such as easy bruising or bleeding, weakness, anemia, bone or joint pain, enlarged liver or spleen, or weakened bones that are easily fractured.
Cerezyme may improve the condition of the liver, spleen, bones, and blood cells in people with Type I Gaucher disease. However, this medicine is not a cure for this condition.
Cerezyme may also be used for purposes other than those listed in this medication guide.
Cerezyme side effects
Get emergency medical help if you have any of these signs of an allergic reaction to Cerezyme: hives; difficult breathing; swelling of your face, lips, tongue, or throat.
Some side effects may occur during or shortly after the injection. Tell your caregiver right away if you feel dizzy, itchy, light-headed, sweaty, or have chest pain, cough, trouble breathing, or flushing (warmth, redness, or tingly feeling).
Call your doctor at once if you have:
Common Cerezyme side effects may include:
Before taking Cerezyme
You should not use Cerezyme if you are allergic to imiglucerase.
To make sure Cerezyme is safe for you, tell your doctor if you have:
FDA pregnancy category C. It is not known whether Cerezyme will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant while using this medicine.
It is not known whether imiglucerase passes into breast milk or if it could harm a nursing baby. Tell your doctor if you are breast-feeding a baby.
Cerezyme should not be given to a child younger than 2 without a doctor's advice.
Relate drugs
- Agalsidase beta
- Aldurazyme
- Alglucerase
- Alglucosidase alfa
- Avalglucosidase alfa
- Avalglucosidase alfa-ngpt
- Myozyme
- Brineura
- Ceredase
- Cerezyme
- Cerliponase alfa
- Elaprase
- Elelyso
- Elfabrio
- Elosulfase alfa
- Fabrazyme
- Galsulfase
- Idursulfase
- Imiglucerase
- Kanuma
- Lamzede
- Laronidase
- Lumizyme
- Mepsevii
- Naglazyme
- Nexviazyme
- Olipudase alfa
- Olipudase alfa-rpcp
- Pegunigalsidase alfa-iwxj
- Pombiliti
- Sebelipase alfa
- Taliglucerase alfa
- Velaglucerase alfa
- Velmanase alfa-tycv
- Vestronidase alfa
- Vestronidase alfa-vjbk
- Vimizim
- VPRIV
- Xenpozyme
How to use Cerezyme
Usual Adult Dose for Gaucher Disease:
Initial dosage: ranges from 2.5 units/kg of body weight 3 times a week to 60 units/kg once every 2 weeks. Imiglucerase for injection is administered by intravenous infusion over 1 to 2 hours. Dosage should be individualized to each patient. Disease severity may dictate that treatment be initiated at a relatively high dose or relatively frequent administration.
Usual Pediatric Dose for Gaucher Disease:
Greater than or equal to 2 years of age: Initial dosage: ranges from 2.5 units/kg of body weight 3 times a week to 60 units/kg once every 2 weeks. Imiglucerase for injection is administered by intravenous infusion over 1 to 2 hours. Dosage should be individualized to each patient. Disease severity may dictate that treatment be initiated at a relatively high dose or relatively frequent administration.
Warnings
Symptoms of allergic reactions including difficulty breathing; closing of the throat; swelling of the lips, tongue, or face; hives; itching; flushing; and dizziness or fainting, have occurred with the use of Cerezyme. Approximately 15% of patients treated with Cerezyme develop antibodies to imiglucerase. Approximately 46% of patients with detectable antibodies have experienced an allergic reaction. Emergency medical attention may be required if an allergic reaction is experienced.
Follow all directions on your medicine label and package. Tell each of your healthcare providers about all your medical conditions, allergies, and all medicines you use.
What other drugs will affect Cerezyme
Other drugs may interact with imiglucerase, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell each of your health care providers about all medicines you use now and any medicine you start or stop using.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions